Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach
- PMID: 30944757
- PMCID: PMC6441770
- DOI: 10.5230/jgc.2019.19.e8
Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach
Erratum in
-
Erratum: Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach.J Gastric Cancer. 2019 Sep;19(3):372-373. doi: 10.5230/jgc.2019.19.e32. Epub 2019 Sep 26. J Gastric Cancer. 2019. PMID: 31598379 Free PMC article.
Conflict of interest statement
Conflict of Interest: No potential conflict of interest relevant to this article was reported.
Figures




Comment in
-
The Necessity of Guidance: Optimizing Adjuvant Therapy for Stage II/III MSI-H Gastric Cancer Through the Interplay of Evidence, Clinical Judgment, and Patient Preferences.J Gastric Cancer. 2024 Jul;24(3):243-245. doi: 10.5230/jgc.2024.24.e26. J Gastric Cancer. 2024. PMID: 38960883 Free PMC article. No abstract available.
References
-
- The Korean Gastric Cancer Association. Korean guideline for gastric cancer. J Korean Gastric Cancer Assoc. 2004;4:286–293.
-
- Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS, Hahn S, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013;66:408–414. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical